Evidence map›Paper›PMID 30725301›Full record

ArticleDigestive diseases and sciences2019

Timely Use of Biologics in Early Crohn's Disease: The Return of "Hit Hard and Early"?

Catherine Le Berre, Silvio Danese, Laurent Peyrin-Biroulet

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Catherine Le BerreINSERM U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, 1 Allée du Morvan, 54 511, Vandœuvre-lès-Nancy, France.
Silvio DaneseIBD Center and Department of Biomedical Sciences, Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.
Laurent Peyrin-BirouletINSERM U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, 1 Allée du Morvan, 54 511, Vandœuvre-lès-Nancy, France. peyrinbiroulet@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsCrohn DiseaseAdalimumabHumansInfliximabIntestinesAdalimumabBiological ProductsInfliximab

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.